private unicorns as an amc by stableton, available via swissquote
in case anyone’s interested in such a product (no affiliation / sq sends me their magazine and the current one has an ad in it).
2 Likes
The fact that Swissquote aggressively pushes these bullshit investment products makes me very suspicous of them as a legitimate broker. Couple that with their fee disadvantage (compared to IB) and recent price hikes and I’m probably out the door in a couple weeks.
3 Likes
i’m not a buyer either, wouldn’t call it bs tho 
I’ve heard of that recently, it is not bad per-se except the usual high fees. But valuation of private companies is inherently difficult, not precise or too generous because of potential conflict of interest ( closeness between VC and owners,…).
If you check the specs here at the bottom, index composition, you can see they are valuating companies mostly on private financing rounds, many done in 20-21 were capital was flowing cheerfully.
EG: Stripe was valued at 95B in 2021 and now is at 50B.
On the other side you just need 1 winner out of 20, from IPO or acquisition, to have some profit.
In conclusion may be worthwhile to allocate a smart bit, but personally I think that it will be difficult that profit less fees will exceed public markets.
1 Like
And if it is a small part of your portfolio (let’s say <5%), is it even worth the hassle/pain for the extra gain ?Especially since you cannot write off losses.
A multimillion fortune with its own wealth trust has a different way for bookkeeping than us normal people.